Social Pulse: Cell Therapeutics Inc (CTIC.W)
CTIC.W on CBOE When Trading NASDAQ Global Select Market
1.15USD
17 May 2013
1.15USD
17 May 2013
Price Change (% chg)
$0.00 (+0.00%)
$0.00 (+0.00%)
Prev Close
$1.15
$1.15
Open
$1.14
$1.14
Day's High
$1.16
$1.16
Day's Low
$1.14
$1.14
Volume
400
400
Avg. Vol
2,713
2,713
52-wk High
$5.10
$5.10
52-wk Low
$1.04
$1.04
- Cell Therapeutics: Addicted to Reverse Stock Splits
- Vosaroxin: A Promising Drug For A Difficult Disease
- Cell Therapeutics Management Discusses Q4 2012 Results - Earnings Call Transcript
- The Soft Underbelly of ZIOPHARM Oncology
- Cell Therapeutics: Research On Tuesday's Run Raises More Questions Than Answers
- JPMorgan Healthcare Conference Highlights: Incyte
Press Releases
- Preclinical Study Provides Potential Mechanisms for Lower Cardiotoxicity in Patients with Multiply Relapsed or Refractory Aggressive B-cell NHL Treated with PixuvriTM Who Received Prior Doxorubicin Therapy
- Cell Therapeutics, Inc.'s (CTI) Board of Directors Approves Amendment of Shareholder Rights Plan
- Cell Therapeutics Reports on Cooperative Group Sponsored Trial of Brostallicin in Patients with Metastatic Triple-Negative Breast Cancer
- CTI Appoints Monique Greer, Senior Vice President, Corporate Communications and Investor Relations
- Cell Therapeutics, Inc. (CTI) to Present at Jefferies 2012 Global Healthcare Conference
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
